UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047820
Receipt number R000054515
Scientific Title Randomized clinical trial comparing treatment outcomes including adverse events of preoperative drainage for acute cholecystitis with endoscopic ultrasound and percutaneous transhepatic approach
Date of disclosure of the study information 2022/05/23
Last modified on 2022/05/21 12:18:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized clinical trial comparing treatment outcomes including adverse events of preoperative drainage for acute cholecystitis with endoscopic ultrasound and percutaneous transhepatic approach

Acronym

RCT comparing the outcomes of endoscopic ultrasound versus percutaneous transhepatic drainage as a preoperative drainage method for acute cholecystitis

Scientific Title

Randomized clinical trial comparing treatment outcomes including adverse events of preoperative drainage for acute cholecystitis with endoscopic ultrasound and percutaneous transhepatic approach

Scientific Title:Acronym

RCT comparing the outcomes of endoscopic ultrasound versus percutaneous transhepatic drainage as a preoperative drainage method for acute cholecystitis

Region

Japan


Condition

Condition

acute cholecystitis

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the outcomes of treatment and the effect on surgical of EUS-GBD and PTGBD

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

early adverse events

Key secondary outcomes

success rate of procedure,clinical efficacy improvement rate,procedure time, hospitalization duration,waiting time for surgery, surgical outcomes (blood loss, operative time, intraoperative adverse events,conversion rate to laparotomy),medical costs (from post-drainage to discharge date), patient QOL


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

EUS-GBD

Interventions/Control_2

PTGBD

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

Patients with acute cholecystitis who are hospitalized at this hospital

Age at the time of enrollment was between 20 and 90 years old

Written consent for participation in the study has been obtained from the patients.

Patients scheduled to undergo LC within 2 months after drainage.

ECOG (Eastern Cooperative Oncology Group) performance status 0-3

Key exclusion criteria

Cases of postoperative reconstructed intestinal tract

Cases with ascites on the liver surface

Cases with difficulty to correct bleeding tendency or coagulation abnormality

Poor gallbladder delineation and difficulty in securing the puncture route

Cases with serious complications in other organs: ASA classification 3 or higher (excluding dialysis patients)

ECOG performance status 4 (see Appendix #2)

Cases with poor general condition and life expectancy judged to be less than 3 months

Cases in which informed consent cannot be obtained

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Ogura

Organization

Osaka Medical and Pharmaceutical University

Division name

2nd depaetment of internal medicine

Zip code

5690801

Address

2-7, Daigakumachi, Takatsuki City, Osaka

TEL

0726831221

Email

oguratakeshi0411@yahoo.co.jp


Public contact

Name of contact person

1st name Atsushi
Middle name
Last name Okuda

Organization

Osaka Medical and Pharmaceutical University

Division name

2nd depaetment of internal medicine

Zip code

5690801

Address

2-7, Daigakumachi, Takatsuki City, Osaka

TEL

0726831221

Homepage URL


Email

ubuntu_koromo@yahoo.co.jp


Sponsor or person

Institute

Osaka Medical and Pharmaceutical University

Institute

Department

Personal name



Funding Source

Organization

Osaka Medical and Pharmaceutical University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka Medical and Pharmaceutical University Research Ethics Committee

Address

2-7, Daigakumachi, Takatsuki City, Osaka

Tel

0726831221

Email

rinri@ompu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 05 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2022 Year 03 Month 01 Day

Date of IRB

2022 Year 05 Month 17 Day

Anticipated trial start date

2022 Year 05 Month 17 Day

Last follow-up date

2026 Year 06 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 05 Month 21 Day

Last modified on

2022 Year 05 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054515


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name